This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

RBC Capital Remains a Buy on CVS Group plc (CVSG)

Tipranks - Tipranks - Wed Nov 4, 4:54AM CST

In a report released today, Charles Weston from RBC Capital reiterated a Buy rating on CVS Group plc, with a price target of p1,800.00.

Weston covers the Healthcare sector, focusing on stocks such as Oxford BioMedica, CVS Group plc, and Smith & Nephew. According to TipRanks, Weston has an average return of -4.3% and a 39.13% success rate on recommended stocks.

CVS Group plc has an analyst consensus of Moderate Buy, with a price target consensus of p1,640.00.

See the top stocks recommended by analysts >>

Based on CVS Group plc’s latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of p355.9 million and a net profit of p9.5 million. In comparison, last year the company earned a revenue of p331.4 million and had a net profit of p8.1 million

Based on the recent corporate insider activity of 10 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of CVSG in relation to earlier this year.

Read More on GB:CVSG:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
Market data provided by Barchart. Exchange delay details and data provider terms here. Information may be delayed, is provided 'as is' and is solely for informational purposes, and not for trading, investment or advice.